Predialysis vascular access creation: To whom and when
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692017000300001 |
Resumo: | Aims: The optimal timing of predialysis vascular access surgery remains uncertain. This study goal was to evaluate the influence of kidney function and clinical characteristics at predialysis vascular access surgery on the likelihood of initiating hemodialysis during follow-up. Methods: Our study retrospectively identified all patients undergoing predialysis arteriovenous fistula creation between 2012-2015. We assessed 3 outcomes: frequency of hemodialysis initiation, death before hemodialysis initiation, and dialysis-free survival after vascular access creation. Multiple variable logistic regression analyzed which factors predicted initiation of dialysis. Results: The study involved 202 patients. Using multiple variable logistic regression, 5 factors were associated with hemodialysis initiation: estimated glomerular filtration rate <10 mL/min/1,73m2 at vascular access placement [OR 4.7, CI: 1.98-8,60, p=0.005], diabetes [OR 2.14, CI: 1.07-4,30, p=0.033], proteinuria>1gr/24 hours [OR 1.88, CI: 0.95-3.71, p=0.049], higher phosphorus levels [OR 6.25, CI: 1.39-13.05, p=0.017] and glomerular filtration rate drop ³3mL/min/1.73m2 in the year preceding vascular surgery [OR 1.67, CI: 0.81-3.45, p=0.016]. Cancer and congestive heart failure were associated with dead before starting dialysis [OR 5.9, CI: 1.15-9.78, p=0.038 and OR 2.4, CI: 1.3-3.9, p=0.021, respectively] and higher hemoglobin (>10g/dL) without erythropoietin stimulating agent levels with survival without needing dialysis [OR 2.34, CI: 1.09-4,58, p=0.028]. Conclusions: Optimizing the timing of vascular access creation in predialysis patients requires consideration not only of the kidney function but also comorbidities such as diabetes, estimated glomerular filtration rate decline in the preceding year and degree of proteinuria |
id |
RCAP_955aaec66dbdd20b4ac6ec40252b88c9 |
---|---|
oai_identifier_str |
oai:scielo:S0872-01692017000300001 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Predialysis vascular access creation: To whom and whenArteriovenous fistulaChronic HemodialysisPre-dialysisVascular AccessAims: The optimal timing of predialysis vascular access surgery remains uncertain. This study goal was to evaluate the influence of kidney function and clinical characteristics at predialysis vascular access surgery on the likelihood of initiating hemodialysis during follow-up. Methods: Our study retrospectively identified all patients undergoing predialysis arteriovenous fistula creation between 2012-2015. We assessed 3 outcomes: frequency of hemodialysis initiation, death before hemodialysis initiation, and dialysis-free survival after vascular access creation. Multiple variable logistic regression analyzed which factors predicted initiation of dialysis. Results: The study involved 202 patients. Using multiple variable logistic regression, 5 factors were associated with hemodialysis initiation: estimated glomerular filtration rate <10 mL/min/1,73m2 at vascular access placement [OR 4.7, CI: 1.98-8,60, p=0.005], diabetes [OR 2.14, CI: 1.07-4,30, p=0.033], proteinuria>1gr/24 hours [OR 1.88, CI: 0.95-3.71, p=0.049], higher phosphorus levels [OR 6.25, CI: 1.39-13.05, p=0.017] and glomerular filtration rate drop ³3mL/min/1.73m2 in the year preceding vascular surgery [OR 1.67, CI: 0.81-3.45, p=0.016]. Cancer and congestive heart failure were associated with dead before starting dialysis [OR 5.9, CI: 1.15-9.78, p=0.038 and OR 2.4, CI: 1.3-3.9, p=0.021, respectively] and higher hemoglobin (>10g/dL) without erythropoietin stimulating agent levels with survival without needing dialysis [OR 2.34, CI: 1.09-4,58, p=0.028]. Conclusions: Optimizing the timing of vascular access creation in predialysis patients requires consideration not only of the kidney function but also comorbidities such as diabetes, estimated glomerular filtration rate decline in the preceding year and degree of proteinuriaSociedade Portuguesa de Nefrologia2017-09-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692017000300001Portuguese Journal of Nephrology & Hypertension v.31 n.3 2017reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692017000300001Escoli,RacheleLuz,IvanSantos,PauloVila Lobos,Anainfo:eu-repo/semantics/openAccess2024-02-06T17:04:55Zoai:scielo:S0872-01692017000300001Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:18:58.601812Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Predialysis vascular access creation: To whom and when |
title |
Predialysis vascular access creation: To whom and when |
spellingShingle |
Predialysis vascular access creation: To whom and when Escoli,Rachele Arteriovenous fistula Chronic Hemodialysis Pre-dialysis Vascular Access |
title_short |
Predialysis vascular access creation: To whom and when |
title_full |
Predialysis vascular access creation: To whom and when |
title_fullStr |
Predialysis vascular access creation: To whom and when |
title_full_unstemmed |
Predialysis vascular access creation: To whom and when |
title_sort |
Predialysis vascular access creation: To whom and when |
author |
Escoli,Rachele |
author_facet |
Escoli,Rachele Luz,Ivan Santos,Paulo Vila Lobos,Ana |
author_role |
author |
author2 |
Luz,Ivan Santos,Paulo Vila Lobos,Ana |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Escoli,Rachele Luz,Ivan Santos,Paulo Vila Lobos,Ana |
dc.subject.por.fl_str_mv |
Arteriovenous fistula Chronic Hemodialysis Pre-dialysis Vascular Access |
topic |
Arteriovenous fistula Chronic Hemodialysis Pre-dialysis Vascular Access |
description |
Aims: The optimal timing of predialysis vascular access surgery remains uncertain. This study goal was to evaluate the influence of kidney function and clinical characteristics at predialysis vascular access surgery on the likelihood of initiating hemodialysis during follow-up. Methods: Our study retrospectively identified all patients undergoing predialysis arteriovenous fistula creation between 2012-2015. We assessed 3 outcomes: frequency of hemodialysis initiation, death before hemodialysis initiation, and dialysis-free survival after vascular access creation. Multiple variable logistic regression analyzed which factors predicted initiation of dialysis. Results: The study involved 202 patients. Using multiple variable logistic regression, 5 factors were associated with hemodialysis initiation: estimated glomerular filtration rate <10 mL/min/1,73m2 at vascular access placement [OR 4.7, CI: 1.98-8,60, p=0.005], diabetes [OR 2.14, CI: 1.07-4,30, p=0.033], proteinuria>1gr/24 hours [OR 1.88, CI: 0.95-3.71, p=0.049], higher phosphorus levels [OR 6.25, CI: 1.39-13.05, p=0.017] and glomerular filtration rate drop ³3mL/min/1.73m2 in the year preceding vascular surgery [OR 1.67, CI: 0.81-3.45, p=0.016]. Cancer and congestive heart failure were associated with dead before starting dialysis [OR 5.9, CI: 1.15-9.78, p=0.038 and OR 2.4, CI: 1.3-3.9, p=0.021, respectively] and higher hemoglobin (>10g/dL) without erythropoietin stimulating agent levels with survival without needing dialysis [OR 2.34, CI: 1.09-4,58, p=0.028]. Conclusions: Optimizing the timing of vascular access creation in predialysis patients requires consideration not only of the kidney function but also comorbidities such as diabetes, estimated glomerular filtration rate decline in the preceding year and degree of proteinuria |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-09-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692017000300001 |
url |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692017000300001 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692017000300001 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Portuguesa de Nefrologia |
publisher.none.fl_str_mv |
Sociedade Portuguesa de Nefrologia |
dc.source.none.fl_str_mv |
Portuguese Journal of Nephrology & Hypertension v.31 n.3 2017 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799137279675990016 |